Nicox Appoints Christine Placet as Director; Michele Garufi Retires from Board of Directors

Nicox, the ophthalmology company, announces the appointment of Christine Placet as a director. She succeeds Michele Garufi, the company’s co-founder, who is stepping down from his role after more than twenty-five years of service. Nicox’s Board of Directors is thus completely renewed to guide its future strategy.

Christine Placet, currently CFO at Theranexus, has significant experience in biotechnology. She played a key role in the growth and sale of Trophos to Roche for €470 million. Her expertise is seen as a major asset for Nicox.

Michele Garufi expressed confidence in Nicox’s new management team to exploit the potential of NCX 470, particularly in the treatment of glaucoma. Damian Marron, Chairman of the Board, praised Garufi’s contribution and looks forward to working with Placet.